Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Niemann-Pick disease, type C1 | Starlite/ChEMBL | No references |
Mus musculus | GLI-Kruppel family member GLI1 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear receptor subfamily 2, group F, member 1 | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Mus musculus | wingless-type MMTV integration site family, member 3A | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0121 | 0.276 | 0.5345 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0024 | 0 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0545 | 0.0545 |
Echinococcus granulosus | geminin | 0.0205 | 0.5163 | 0.5163 |
Onchocerca volvulus | 0.0024 | 0 | 0.5 | |
Brugia malayi | CHE-14 protein | 0.0051 | 0.0762 | 0.0762 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0024 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.1091 | 0.1091 |
Echinococcus multilocularis | protein patched | 0.0051 | 0.0762 | 0.0762 |
Echinococcus granulosus | zinc finger transcription factor gli2 | 0.0373 | 1 | 1 |
Echinococcus granulosus | expressed conserved protein | 0.0112 | 0.25 | 0.25 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0133 | 0.3109 | 0.3109 |
Loa Loa (eye worm) | zinc finger protein | 0.0373 | 1 | 1 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.017 | 0.4169 | 0.4169 |
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0119 | 0.2707 | 0.2707 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.071 | 0.1375 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.028 | 0.7314 | 0.7314 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0051 | 0.0762 | 0.0762 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0545 | 0.0545 |
Echinococcus multilocularis | protein dispatched 1 | 0.0058 | 0.0969 | 0.0969 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.5163 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.071 | 0.1375 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.2779 | 0.2779 |
Brugia malayi | follicle stimulating hormone receptor | 0.028 | 0.7314 | 0.7314 |
Echinococcus multilocularis | expressed conserved protein | 0.0112 | 0.25 | 0.25 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0545 | 0.1056 |
Loa Loa (eye worm) | nuclear hormone receptor | 0.012 | 0.274 | 0.274 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0119 | 0.2707 | 0.2707 |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0119 | 0.2707 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0024 | 0 | 0.5 |
Schistosoma mansoni | patched 1 | 0.0051 | 0.0762 | 0.1477 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0119 | 0.2707 | 0.2707 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0133 | 0.3109 | 0.3109 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0051 | 0.0762 | 0.0762 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.017 | 0.4169 | 0.4169 |
Echinococcus multilocularis | zinc finger transcription factor gli2 | 0.0373 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.5163 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.071 | 0.1375 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 0.0762 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.2707 | 0.2707 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0051 | 0.0762 | 0.0762 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.071 | 0.1375 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0133 | 0.3109 | 0.3109 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0762 | 0.0762 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0545 | 0.0545 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0545 | 0.1056 |
Echinococcus multilocularis | geminin | 0.0205 | 0.5163 | 0.5163 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0051 | 0.0762 | 0.0762 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 0.338 uM | PubChem BioAssay. Dose response validation of uHTS Gli-SUFU antagonist hits in a Wnt3a luminescent reporter assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 1.53 uM | PubChem BioAssay. Dose response confirmation of uHTS antagonist hits from Gli-SUFU in a luminescent reporter assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 2.579 uM | PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay to identify inhibitors of COUP-TFII (NR2F2). (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 85.388 uM | PubChem BioAssay. Counterscreen for inhibitors of COUP-TFII (NR2F2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.5174 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1.2589 um | PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.3109 uM | PubChem BioAssay. Nrf2 qHTS screen for inhibitors: Nrf2 A549 ARE-Fluc Confirmation Assay for Hit Validation. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.6626 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 13.4591 uM | PUBCHEM_BIOASSAY: qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.